|
Magyar Tüdőgyógyász Társaság |
|
A táplálék allergiák immunológiai, kémiai és klinikai problémáinak 9. Nemzetközi szimpóziuma |
Rendezvény kezdete: 2004.04.18. | Rendezvény vége: 2004.04.21. |
Tudományos információ: Prof. Dr. Nékám Kristóf |
Munkahely neve: Budai Irgalmasrendi Kórház |
Címe: 1023 Budapest, Árpád fejedelem útja 7. |
Tel: 335-0915 |
Fax: 335-0915 |
E-mail: nekamkr.allergy@mail.datanet.hu |
Helyszín: Budapest, Hotel Hilton |
Előadók:
Sunday, 18th April 2004 10:00 - 20.00 Registration Opening of the Conference 17.00 - 17.30 Welcome, Introduction K. Nékám (Hungary) 17.30 - 17.50 Food Allergy - An Increasing Clinical Problem C.Ortolani (Italy) 17.50 - 18.10 Legislative Aspects and Regulation J.Humieres (Belgium) 18.10 - 18.30 From Structure to Biological Activity B.M. Stadler (Switzerland) 18.30 - 20.00 Welcome Reception
Monday, 19th April 2004 Symposium 1: Basic Immunologial Problems in Food Allergy Chair: H. Steinhart (Germany) Co-chair: C. Ortolani(Italy) 08.30 - 09.00 Immunological Mechanisms in Food Allergy P.Brandfzaeg (Norway) 09.00 - 09.30 Response to Oral Antigens in the Gut T.T. MacDonald (United Kingdom) 09.30 - 10.00 Non-IgE Mediated Food Allergy S. Sicherer(USA) 10.00 - 10.30 Coffee Break Symposium 2: Allergen Structures, Interactions & Biological Activities Chair: R. Marchelli (Italy) Co-Chair: L. Simon-Sarkadi (Hungary) 10.30 - 10.55 Structure of Recombinant Food Allergens K. Hoffmann-Sommergruber (Austria) 10.55 - 11.20 Allergenicity Versus Immunogenicity C. Mills (United Kingdom) 11.20 - 11.45 Synthetic Peptides and IgE Mapping G. Reese (Germany) 11.45 - 11.55 The Characterization of the T Cell Response to Cor a 1.04, the Major Allergen in Hazelnuts: a hard nut to crack? B. Bohle (Austria) 11.55 - 12.05 Are Protein Structural Features Involved in the "Intrinsic" Allergenicity of 2S Albumins? - a Protein Microarray Approach. J.Lin (United Kingdom) 12.05 - 12.15 Food Allergy to Wheat : Identification of IgE Binding Proteins and Epitopes S.Denery-Papini (France) 12.15 - 14.00 Lunch & Poster viewing 14.00 - 14.25 Structure and Function of Milk Allergens J.-M. Wahl (France) 14.25 - 14.50 Structure Elucidation H. Helsper(The Netherlands) 14.50 - 15.15 Genetic Engineering of Plants to Reduce Food Allergens: Potentials and Limitations U. Sonnewald (Germany) 15.15 - 15.30 Coffee Break Special ILSI Europe Session: Allergen Thresholds to Protect Consumers? Chair: R. Crevel (United Kingdom) Co-chair: S.Taylor(USA) Rapporteur: C.Hischenhuber (Switzerland) 15.30 - 15.50 Concept of Risk Assessment for Allergens M. Lovik(Norway) 15.50 - 16.10 Current Available Data A. Knulst (The Netherlands) 16.10 - 16.30 How to Establish a Threshold S.Taylor (USA) 16.30 - 16.50 Concept of Thresholds for Allergens T. Hatzold (Germany) 16.50 - 17.10 Patient Perspective J. Salter (Canada) 17.10 - 17.30 Exemption Criteria for Allergens C.Madsen (Denmark) 17.30 - 17.50 Panel Discussion 20:00 Concert at Matthias Church
Tuesday, 20th April 2004 Symposium 3: Food Allergy and Anaphylaxis Chair: K. Nékám (Hungary) Co-chair: C.Bindslev-Jensen (Denmark) 09.00 - 09.25 Cross-reactions in Food Allergy R. van Ree (The Netherlands) 09.25 - 09.50 Epidemiology of Fatal Food Allergy R. Pumphrey (United Kingdom) 09.50 - 10.15 Incidence of Anaphylaxis due to Food Allergy E. Pastorello (Italy) 10.15 - 10.40 Clinical Diagnosis of Food Allergy C. Bindslev-Jensen (Denmark) 10.40- 11.10 Coffee Break 11.10 - 11.20 Inadequate Labelling, Contamination or Inadvertent Consumption as Causes of Allergic Reactions to Food I.Malmheden Yman (Sweden) 11.20 - 11.30 Apple-Dependent Exercise-Induced Urticaria M.Patafi (Italy) 11.30 - 12.15 Poster Discussion Selected Posters on Epidemiology of Food Allergy (5' minutes presentations) 12.15 - 13.30 Lunch Symposium 4: Progress in Analytical Methodology Technology for Detection of Food Allergen Chair: E. Anklam (Belgium) Co-chair: R. Battaglia (Switzerland) 13.30 - 13.55 Reference Materials and Reference Systems C.L. Klein (Belgium) 13.55 - 14.20 Towards Standardised Test Methods (CEN) S. Vieths (Germany) 14.20 - 14.45 Processing Effects and other Considerations in Testing S.Hefle (USA) 14.45 - 15.10 Experiences with Commercial Test Kits C. Hischenhuber(Switzerland) 15.10 - 15.35 Coffee Break 15.35 - 16.00 Methodological Developments: An Overview R. Poms (Belgium) 16.00 - 16.25 Allergen Contamination in Food Industry P. Koch (Switzerland) 16.25 - 16.50 Low Allergen Food Technology A.Paschke (Germany) 16.50 - 17.00 Evaluation of the Potential Allergenicity of Microbial Transglutaminase Using the 2001 FAO/WHO Decision Tree M.H.Pedersen (Denmark) 19.30 Conference Banquet (optional)
Wednesday, 21st April 2004 Symposium 5: Digestion, Absorption and Processing of Food Allergens - Prevention of Food Allergy Chair: C. Mills (USA) Co-Chair: A. Muraro (Italy) 09.00 - 09.25 Overview on Digestion of Absorption of Proteins A. Fillery-Travis (United Kingdom) 09.25 - 09.50 Prevention of Food Allergy A. Muraro(Italy) 09.50 - 10.15 Prediction of Tolerance in Food Allergy S. Murch 10.15 - 10.25 The Effect of Gastrointestinal Digestion on 2S Albumin from Brazil Nut F.J.Moreno (United Kingdom) 10.25 - 10.35 Lactose Malabsorption and Multiple Sensitization to Food Allergens: Evidence of Correlation M. Failla(Italy) 10.35 - 10.45 Immune Response in Mice to Ingested Soy Protein: Antibody Production, Oral Tolerance and Maternal Transfer H.R.Christensen (Denmark) 10.45 - 11.15 Coffee Break 11.15 - 11.40 Recombinant Food Allergens S. Spitzauer(Austria) 11.40 - 12.05 The Role of Atopy Patch Test in Diagnosis B. Niggemann (Germany) 12.05 - 12.30 Anti-IgE to Raise the Threshold of Elicitation W. Burks (USA) 12.30 - 12.40 Plant Food Allergies: Field to table Strategies for Reducing their Incidence in Europe (Safe) A.I.Sancho(United Kingdom) 12.40 - 12.50 Anti-ulcer drugs promote food allergy in mouse and man Jensen-Jarolim E. (Vienna, Austria) 12.50 - 13.00 Quantification of Ara h 1 in Peanuts: Does Roasting Make a Difference ? A.Pomés (USA) 13.00 - 13.30 Closing Remarks K. Nékám (Hungary) 13.30 End of Symposium Honlap: http://www.foodallergy.makit.hu/ |
|
|
|
|
Magyar Kardiológusok Társasága |
|
14th International Congress on Cardiovascular Pharmacotherapy |
Rendezvény kezdete: 2007.11.28. | Rendezvény vége: 2007.12.02. |
Tudományos információ: Ali Oto, MD, FESC, FACC, FHRS |
Címe: Cinnah Cad. 98/4 Çankaya 06550, Ankara - TURKEY |
Tel: +90 312 440 20 21 |
Fax: +90 212 258 60 78 |
E-mail: iscp2007@figur.net |
Helyszín: Törökország, Antalya, Sungate Port Royal Resort |
A rendezvény Web oldala: http://www.iscp2007.org |
Dear Colleagues,
It is a great pleasure for me to invite you to the 14th Congress of the International Society of Cardiovascular Pharmacotherapy (ISCP) which will be held in one of the pearls of the Mediterranean, Antalya, Turkey.
Over the last two decades the Congresses of the ISCP have always been major scientific events in the field of the medical therapy of the cardiovascular diseases and created a world forum for knowledge sharing and exchanging ideas. Clinical trials as the cornerstone of the evidence based cardiology and late breaking trials will be the new faces of the ISCP Congress in 2007 besides the continuation of the tradition.
Cardiovascular pharmacotherapy covers a wide spectrum of therapeutics and such a spectrum will be provided in the Congress from preventive drug therapy to gene based and cellular therapy.
The scientific platform, the collegial atmosphere and the historical and natural beauty of the venue show adequate evidence for choosing the 14th Congress of the ISCP to send your valuable works and to attend.
Looking forward to seeing you in Antalya,
Ali Oto, MD, FESC, FACC, FHRS
President
Main topics:
• Preventive Cardiology
• Antithrombotic and Anti-Platelet Therapy
• Fibrinolytic Therapy
• Drug Therapy for Dislipidemias
• Antihypertensive Therapy
• Antiarrhythmic Therapy
• Medical Treatment in Acute Coronary Syndromes
• Treatment Strategies in Stable Angina Pectoris
• Cell Based Therapy for Cardiovascular Diseases
• Gene Based Therapy for Cardiovascular Diseases
• Optimal Pharmacotherapy of Heart Failure
• Pharmacotherapy in Cardiac Transplant Patients
• Treatment of Pulmonary Hypertension
• Inflammation and Anti-Inflammatory Therapy in Cardiovascular Medicine
• Diabetes as a Cardiovascular Disease
• Treatment of Obesity
• Medical Aid in Smoking Cessation
További részletek a kongresszus web-oldalán: http://www.iscp2007.org |
|
Kapcsolódó dokumentumok (3)
|
|
|
Magyar Kardiológusok Társasága |
|
14th International Congress on Cardiovascular Pharmacotherapy |
Rendezvény kezdete: 2007.11.28. | Rendezvény vége: 2007.12.02. |
Tudományos információ: Ali Oto, MD, FESC, FACC, FHRS |
Címe: Cinnah Cad. 98/4 Çankaya 06550, Ankara - TURKEY |
Tel: +90 312 440 20 21 |
Fax: +90 212 258 60 78 |
E-mail: iscp2007@figur.net |
Helyszín: Törökország, Antalya, Sungate Port Royal Resort |
A rendezvény Web oldala: http://www.iscp2007.org |
Dear Colleagues,
It is a great pleasure for me to invite you to the 14th Congress of the International Society of Cardiovascular Pharmacotherapy (ISCP) which will be held in one of the pearls of the Mediterranean, Antalya, Turkey.
Over the last two decades the Congresses of the ISCP have always been major scientific events in the field of the medical therapy of the cardiovascular diseases and created a world forum for knowledge sharing and exchanging ideas. Clinical trials as the cornerstone of the evidence based cardiology and late breaking trials will be the new faces of the ISCP Congress in 2007 besides the continuation of the tradition.
Cardiovascular pharmacotherapy covers a wide spectrum of therapeutics and such a spectrum will be provided in the Congress from preventive drug therapy to gene based and cellular therapy.
The scientific platform, the collegial atmosphere and the historical and natural beauty of the venue show adequate evidence for choosing the 14th Congress of the ISCP to send your valuable works and to attend.
Looking forward to seeing you in Antalya,
Ali Oto, MD, FESC, FACC, FHRS
President
Main topics:
• Preventive Cardiology
• Antithrombotic and Anti-Platelet Therapy
• Fibrinolytic Therapy
• Drug Therapy for Dislipidemias
• Antihypertensive Therapy
• Antiarrhythmic Therapy
• Medical Treatment in Acute Coronary Syndromes
• Treatment Strategies in Stable Angina Pectoris
• Cell Based Therapy for Cardiovascular Diseases
• Gene Based Therapy for Cardiovascular Diseases
• Optimal Pharmacotherapy of Heart Failure
• Pharmacotherapy in Cardiac Transplant Patients
• Treatment of Pulmonary Hypertension
• Inflammation and Anti-Inflammatory Therapy in Cardiovascular Medicine
• Diabetes as a Cardiovascular Disease
• Treatment of Obesity
• Medical Aid in Smoking Cessation
További részletek a kongresszus web-oldalán: http://www.iscp2007.org |
|
Kapcsolódó dokumentumok (3)
|
|
|
Magyar Kardiológusok Társasága |
|
14th International Congress on Cardiovascular Pharmacotherapy |
Rendezvény kezdete: 2007.11.28. | Rendezvény vége: 2007.12.02. |
Tudományos információ: Ali Oto, MD, FESC, FACC, FHRS |
Címe: Cinnah Cad. 98/4 Çankaya 06550, Ankara - TURKEY |
Tel: +90 312 440 20 21 |
Fax: +90 212 258 60 78 |
E-mail: iscp2007@figur.net |
Helyszín: Törökország, Antalya, Sungate Port Royal Resort |
A rendezvény Web oldala: http://www.iscp2007.org |
Dear Colleagues,
It is a great pleasure for me to invite you to the 14th Congress of the International Society of Cardiovascular Pharmacotherapy (ISCP) which will be held in one of the pearls of the Mediterranean, Antalya, Turkey.
Over the last two decades the Congresses of the ISCP have always been major scientific events in the field of the medical therapy of the cardiovascular diseases and created a world forum for knowledge sharing and exchanging ideas. Clinical trials as the cornerstone of the evidence based cardiology and late breaking trials will be the new faces of the ISCP Congress in 2007 besides the continuation of the tradition.
Cardiovascular pharmacotherapy covers a wide spectrum of therapeutics and such a spectrum will be provided in the Congress from preventive drug therapy to gene based and cellular therapy.
The scientific platform, the collegial atmosphere and the historical and natural beauty of the venue show adequate evidence for choosing the 14th Congress of the ISCP to send your valuable works and to attend.
Looking forward to seeing you in Antalya,
Ali Oto, MD, FESC, FACC, FHRS
President
Main topics:
• Preventive Cardiology
• Antithrombotic and Anti-Platelet Therapy
• Fibrinolytic Therapy
• Drug Therapy for Dislipidemias
• Antihypertensive Therapy
• Antiarrhythmic Therapy
• Medical Treatment in Acute Coronary Syndromes
• Treatment Strategies in Stable Angina Pectoris
• Cell Based Therapy for Cardiovascular Diseases
• Gene Based Therapy for Cardiovascular Diseases
• Optimal Pharmacotherapy of Heart Failure
• Pharmacotherapy in Cardiac Transplant Patients
• Treatment of Pulmonary Hypertension
• Inflammation and Anti-Inflammatory Therapy in Cardiovascular Medicine
• Diabetes as a Cardiovascular Disease
• Treatment of Obesity
• Medical Aid in Smoking Cessation
További részletek a kongresszus web-oldalán: http://www.iscp2007.org |
|
Kapcsolódó dokumentumok (3)
|
|
|
Magyar Kardiológusok Társasága |
|
14th International Congress on Cardiovascular Pharmacotherapy |
Rendezvény kezdete: 2007.11.28. | Rendezvény vége: 2007.12.02. |
Tudományos információ: Ali Oto, MD, FESC, FACC, FHRS |
Címe: Cinnah Cad. 98/4 Çankaya 06550, Ankara - TURKEY |
Tel: +90 312 440 20 21 |
Fax: +90 212 258 60 78 |
E-mail: iscp2007@figur.net |
Helyszín: Törökország, Antalya, Sungate Port Royal Resort |
A rendezvény Web oldala: http://www.iscp2007.org |
Dear Colleagues,
It is a great pleasure for me to invite you to the 14th Congress of the International Society of Cardiovascular Pharmacotherapy (ISCP) which will be held in one of the pearls of the Mediterranean, Antalya, Turkey.
Over the last two decades the Congresses of the ISCP have always been major scientific events in the field of the medical therapy of the cardiovascular diseases and created a world forum for knowledge sharing and exchanging ideas. Clinical trials as the cornerstone of the evidence based cardiology and late breaking trials will be the new faces of the ISCP Congress in 2007 besides the continuation of the tradition.
Cardiovascular pharmacotherapy covers a wide spectrum of therapeutics and such a spectrum will be provided in the Congress from preventive drug therapy to gene based and cellular therapy.
The scientific platform, the collegial atmosphere and the historical and natural beauty of the venue show adequate evidence for choosing the 14th Congress of the ISCP to send your valuable works and to attend.
Looking forward to seeing you in Antalya,
Ali Oto, MD, FESC, FACC, FHRS
President
Main topics:
• Preventive Cardiology
• Antithrombotic and Anti-Platelet Therapy
• Fibrinolytic Therapy
• Drug Therapy for Dislipidemias
• Antihypertensive Therapy
• Antiarrhythmic Therapy
• Medical Treatment in Acute Coronary Syndromes
• Treatment Strategies in Stable Angina Pectoris
• Cell Based Therapy for Cardiovascular Diseases
• Gene Based Therapy for Cardiovascular Diseases
• Optimal Pharmacotherapy of Heart Failure
• Pharmacotherapy in Cardiac Transplant Patients
• Treatment of Pulmonary Hypertension
• Inflammation and Anti-Inflammatory Therapy in Cardiovascular Medicine
• Diabetes as a Cardiovascular Disease
• Treatment of Obesity
• Medical Aid in Smoking Cessation
További részletek a kongresszus web-oldalán: http://www.iscp2007.org |
|
Kapcsolódó dokumentumok (3)
|
|
|
Magyar Kardiológusok Társasága |
|
14th International Congress on Cardiovascular Pharmacotherapy |
Rendezvény kezdete: 2007.11.28. | Rendezvény vége: 2007.12.02. |
Tudományos információ: Ali Oto, MD, FESC, FACC, FHRS |
Címe: Cinnah Cad. 98/4 Çankaya 06550, Ankara - TURKEY |
Tel: +90 312 440 20 21 |
Fax: +90 212 258 60 78 |
E-mail: iscp2007@figur.net |
Helyszín: Törökország, Antalya, Sungate Port Royal Resort |
A rendezvény Web oldala: http://www.iscp2007.org |
Dear Colleagues,
It is a great pleasure for me to invite you to the 14th Congress of the International Society of Cardiovascular Pharmacotherapy (ISCP) which will be held in one of the pearls of the Mediterranean, Antalya, Turkey.
Over the last two decades the Congresses of the ISCP have always been major scientific events in the field of the medical therapy of the cardiovascular diseases and created a world forum for knowledge sharing and exchanging ideas. Clinical trials as the cornerstone of the evidence based cardiology and late breaking trials will be the new faces of the ISCP Congress in 2007 besides the continuation of the tradition.
Cardiovascular pharmacotherapy covers a wide spectrum of therapeutics and such a spectrum will be provided in the Congress from preventive drug therapy to gene based and cellular therapy.
The scientific platform, the collegial atmosphere and the historical and natural beauty of the venue show adequate evidence for choosing the 14th Congress of the ISCP to send your valuable works and to attend.
Looking forward to seeing you in Antalya,
Ali Oto, MD, FESC, FACC, FHRS
President
Main topics:
• Preventive Cardiology
• Antithrombotic and Anti-Platelet Therapy
• Fibrinolytic Therapy
• Drug Therapy for Dislipidemias
• Antihypertensive Therapy
• Antiarrhythmic Therapy
• Medical Treatment in Acute Coronary Syndromes
• Treatment Strategies in Stable Angina Pectoris
• Cell Based Therapy for Cardiovascular Diseases
• Gene Based Therapy for Cardiovascular Diseases
• Optimal Pharmacotherapy of Heart Failure
• Pharmacotherapy in Cardiac Transplant Patients
• Treatment of Pulmonary Hypertension
• Inflammation and Anti-Inflammatory Therapy in Cardiovascular Medicine
• Diabetes as a Cardiovascular Disease
• Treatment of Obesity
• Medical Aid in Smoking Cessation
További részletek a kongresszus web-oldalán: http://www.iscp2007.org |
|
Kapcsolódó dokumentumok (3)
|
|